vimarsana.com

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price target.  “At...

Related Keywords

,Remote Monitoring Solutions ,Fresenius ,Cardiac Remote Monitoring Solutions ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.